发明名称 |
Systems and methods for glycemic control during pump disconnection |
摘要 |
Techniques and devices are described for allowing a diabetes patient to safely disconnect an insulin infusion system device for a time period. In one aspect, the techniques and devices can be implemented by receiving a maximum glucose amount, a minimum glucose amount, and a contemplated disconnection time; receiving a current glucose amount of the user; determining an expected increase in glucose of the user based on the contemplated disconnection time, an insulin sensitivity of the user and a contemplated basal insulin dose; validating the contemplated disconnection time based on at least one of the expected increase in glucose, the maximum glucose amount, and the minimum glucose amount; and, administering a therapeutic action to the user based on the validation of the contemplated disconnection time. |
申请公布号 |
US8911423(B2) |
申请公布日期 |
2014.12.16 |
申请号 |
US200812170936 |
申请日期 |
2008.07.10 |
申请人 |
Roche Diagnostics Operations, Inc. |
发明人 |
Yodfat Ofer;Shapira Gali |
分类号 |
A61M31/00;A61M5/172;A61M5/142 |
主分类号 |
A61M31/00 |
代理机构 |
Roche Diagnostics Operations, Inc. |
代理人 |
Roche Diagnostics Operations, Inc. |
主权项 |
1. A method for controlled disconnection of a therapeutic treatment device comprising:
providing a processor for at least one of programming and operating the treatment device; receiving a current amount of glucose in a user's body; automatically determining, by the processor, an amount of insulin for dispensing into the user's body as a function of the current amount of glucose and a contemplated disconnection time; and upon the processor determining an amount of insulin for dispensing, initiating dispensing of the determined amount of insulin into the user's body without additional user input of a percentage of the determined amount of insulin for dispensing into the user's body. |
地址 |
Indianapolis IN US |